I don't follow ICPT as closely as others here. In general I don't like co-primary endpoints in reading Adam's writeup it seems they missed on NASH resolution in Phase 2 granted the larger trial size should help here. That being said and not being knowledgeable here it would be a guess but I would guess higher than 20% odds of success
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.